What the company does
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved …
What the weekly tape is saying
CIPLA closed the latest completed week at 1,389 INR. The 4-week return is -2.1% and the 12-week return is 10.6%. Trend Signal is inactive, Market Dynamics is 0.83. Setup signature: Balanced read with a 46/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,371 INR
- Vs Trend Line
- 1.3%
- Fair Value
- 1,402 INR
- Vs Fair Value
- -0.9%
- 52W High
- 1,673 INR
- 52W Low
- 1,155 INR
- Drawdown
- -17.0%
- Range Position
- 45.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 25
- 52W Active Breadth
- 48.1%
- Sector Scope
- IN Healthcare
- Sector Rank
- 105 of 161
- Sector Percentile
- 35.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
IN Healthcare
- Tracked Peers
- 100
- 4W Rank
- 69 of 100
- Avg 1W
- 2.2%
- Avg 4W
- 5.7%
- Trend Breadth
- 55.0%
- Positive MD
- 90.0%
IN Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 92
- 4W Rank
- 68 of 92
- Avg 1W
- 2.0%
- Avg 4W
- 7.4%
- Trend Breadth
- 50.0%
- Positive RS
- 65.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.83
- 4W MD Change
- 55.7%
- Relative Strength
- 1.70
- 4W RS Change
- -54.2%
- Expectation
- Positive
- Probability
- 57.91%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 4.5M
- 13W Average
- 8.8M
- 52W Average
- 7.5M
- Vs 13W
- 0.5x
- Vs 52W
- 0.6x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.1%
- 52W Volatility
- 2.5%
- Upside Weeks
- 28
- Downside Weeks
- 24
- Downside Breadth
- 46.2%
- Avg Gain / Loss
- 1.6% / -2.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NSI
- Country
- IN
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- INR
- Market Cap
- 1131.7B
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1,389 INR | -0.8% | 1,371 INR | 1,402 INR | 0.83 | 1.70 | 4.5M | Off |
| 5 Jun 2026 | 1,401 INR | 1.0% | 1,376 INR | 1,399 INR | 1.03 | 3.65 | 7.1M | Off |
| 29 May 2026 | 1,388 INR | 0.1% | 1,379 INR | 1,396 INR | 0.97 | 1.89 | 12.3M | Off |
| 22 May 2026 | 1,386 INR | -2.3% | 1,383 INR | 1,393 INR | 0.70 | 1.04 | 6.8M | Off |
| 15 May 2026 | 1,419 INR | 6.3% | 1,390 INR | 1,390 INR | 0.53 | 3.72 | 19.1M | Off |
| 8 May 2026 | 1,334 INR | 2.9% | 1,395 INR | 1,387 INR | -0.09 | -4.57 | 6.3M | Off |
| 1 May 2026 | 1,297 INR | 1.1% | 1,403 INR | 1,384 INR | -0.47 | -6.71 | 5.6M | Off |
| 24 Apr 2026 | 1,283 INR | 4.4% | 1,410 INR | 1,382 INR | -0.85 | -7.59 | 13.5M | Off |
| 17 Apr 2026 | 1,229 INR | 0.9% | 1,417 INR | 1,379 INR | -1.28 | -13.38 | 7.0M | Off |
| 10 Apr 2026 | 1,218 INR | 3.1% | 1,429 INR | 1,377 INR | -1.37 | -13.44 | 11.3M | Off |
| 3 Apr 2026 | 1,181 INR | -4.9% | 1,441 INR | 1,375 INR | -1.49 | -11.48 | 7.4M | Off |
| 27 Mar 2026 | 1,242 INR | -1.1% | 1,453 INR | 1,373 INR | -1.50 | -7.62 | 5.8M | Off |
| 20 Mar 2026 | 1,256 INR | -4.4% | 1,464 INR | 1,371 INR | -1.38 | -7.95 | 8.0M | Off |
| 13 Mar 2026 | 1,315 INR | -0.5% | 1,476 INR | 1,368 INR | -1.40 | -4.15 | 6.7M | Off |